Andrew Holden, MBChB

CIO 2023-2 Feasibility of CT Based Tumor Dosimetry Using Multimodal Imageable Glass Eye90 Microspheres

Purpose: To demonstrate proof of concept for CT based tumor dosimetry after treatment of Hepatocellular Carcinoma (HCC) with multimodal imageable yttrium-90 (90Y) microspheres (Eye90 micr...

Amit Verma , DrPH, MPH;

David Dobrowski ;

Adam Kulp , PhD;

Eric Henry , PhD;

S. Cheenu Kappadath , PhD;

Aravind Arepally , MD;

Andrew Holden , MBChB;

11/01/2023

CIO 2022-2 Embolization of Primary and Secondary Renal Cell Carcinoma Tumors with the GPX Embolic Device

Purpose: The GPX Embolic System is a novel embolic agent designed for use in durable and preoperative transcatheter embolization procedures. The GPX Embolic Material is a low-viscosity fl...

Martin Krauss ;

Ryan O'Hara ;

Colin T. Phillips , MD;

J. Jones ;

Andrew Holden , MBChB;

10/18/2022

Interview

Results of the GPX Embolic Device Clinical Trial: An Interview With Dr. Andrew Holden

04/20/2023

Andrew Holden , MBChB;

At the 2023 Society of Interventional Radiologists Annual Meeting in Phoenix, Arizona, Interventional Radiologist Andrew Holden, ONZM, MBChB, FRANZCR, EBIR, from Auckland City Hospital in New Zealand, presented final results from the GPX...

At the 2023 Society of...

04/20/2023

Vascular Disease Management

Abdominal Aortic Aneurysm Sac Healing with a Bioabsorbable Shape Memory Polymer

Purpose: To determine the safety and feasibility of filling an abdominal aortic aneurysm (AAA) sac with a novel, bioabsorbable embolic device at the time as endovascular aneurysm repair (...

Andrew Holden , MBChB;

Michel M.P.J. Reijnen , MD, PhD;

A. Hill ;

01/14/2022

Meeting Exclusive

DISRUPT PAD III Update: Intravascular Lithotripsy for PAD

07/08/2021

Debra L. Beck , MSc;

Andrew Holden , MBChB;

Written by Debra L. Beck, MSc; Presented by Andrew Holden, MBChB

Written by Debra L. Beck, MSc;...

07/08/2021